Kevin Okeefe, MD
Internal Medicine · Annapolis, MDNPI 1841398633
Payments from drug & device makers
Across 6 payments — averaging $24.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$82
- Philips North America LLC$28
- Almatica Pharma LLC$21
- Cook Medical LLC$18
What the payments were for
- Travel & lodging$8255%
- Food & beverage$6845%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1 | $82 |
| Philips North America LLC | 2 | $28 |
| Almatica Pharma LLC | 1 | $21 |
| Cook Medical LLC | 2 | $18 |
How this compares
$149 in reported general payments places this provider in the 45th percentile of 2,979 internal medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 295 | $389,232 |
| MounjaroTirzepatide | 205 | $230,502 |
| EliquisApixaban | 126 | $192,529 |
| JardianceEmpagliflozin | 125 | $153,219 |
| XareltoRivaroxaban | 68 | $96,818 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $46,085 |
| FarxigaDapagliflozin Propanediol | 33 | $45,358 |
| WegovySemaglutide | 27 | $38,969 |
| LinzessLinaclotide | 36 | $31,603 |
| TrulicityDulaglutide | 20 | $31,221 |
| Tresiba Flextouch U-100Insulin Degludec | 11 | $29,500 |
| ProliaDenosumab | 12 | $21,637 |
| Dexlansoprazole DrDexlansoprazole | 56 | $20,243 |
| XifaxanRifaximin | 12 | $19,596 |
| Victoza 3-PakLiraglutide | 12 | $17,633 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Annapolis
- Titus AbrahamAnnapolis$1.7M
- James WelkerAnnapolis$823K
- Brian HarveyAnnapolis$220K
- Shishir KhetanRockville$52.1M
- Steven GellerElkridge$15.1M
- Mary HowellHagerstown$6.2M
- Kristen MarroneBaltimore$5.6M
- Jonathan CohenRockville$5M
- Andrea ApoloBethesda$4.8M
- Peta-Gay Jackson BoothBaltimore$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.